Skip to main content

C32.1 vs D49.1

C32.1 (Malignant neoplasm of supraglottis) compared with D49.1 (Neoplasm of unspecified behavior of respiratory system), from the official CMS tabular data. C32.1 and D49.1 name the same anatomical site (aryepiglottic fold) with a different neoplasm behavior. MedCoder-derived

Relationship

Informational

Neoplasm table relationship

D49.1
Neoplasm of unspecified behavior of respiratory system
C32.1
Malignant neoplasm of supraglottis

Same anatomical site, different neoplasm behavior.

Same site — primary malignancy (aryepiglottic fold)

The behavior documented for the site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column of the neoplasm table, and therefore which code, applies.

Source: CMS Table of Neoplasms

Can these codes be reported together?

Same site, different neoplasm behavior. D49.1 and C32.1 name the same anatomical site (aryepiglottic fold) with a different neoplasm behavior.

From the CMS/CDC Table of Neoplasms: the behavior documented for that site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column, and therefore which code, applies.

Side by side

C32.1Malignant neoplasm of supraglottisD49.1Neoplasm of unspecified behavior of respiratory system
Billing statusBillableBillable
ClassificationC00-D49 — NeoplasmsC00-D49 — Neoplasms
DefinitionMalignant neoplasm of supraglottis is a billable ICD-10-CM diagnosis code (C32.1).Neoplasm of unspecified behavior of respiratory system is a billable ICD-10-CM diagnosis code (D49.1).
Includes
malignant neoplasm of middle ear
Malignant neoplasm of aryepiglottic fold or interarytenoid fold, laryngeal aspect
Malignant neoplasm of epiglottis (suprahyoid portion) NOS
Malignant neoplasm of extrinsic larynx
'growth' NOS
neoplasm NOS
new growth NOS
tumor NOS
Use additional code
code to identify:
alcohol abuse and dependence (F10.-)
exposure to environmental tobacco smoke (Z77.22)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources